3
Announcements
Trials
Browse
Landscape
Status
Recruiting
27
Active not recruiting
10
Not yet recruiting
9
Completed
8
Terminated
3
Withdrawn
1
Suspended
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
4
Multiple Myeloma
3
Melanoma
3
Lung Neoplasms
3
Recurrence
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neuroblastoma
2
Neoplasms
2
Glioblastoma
2
Wilms Tumor
1
Uterine Neoplasms
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Pinealoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms by Site
1
Meningeal Neoplasms
1
Interventions
capmatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
Adenocarcinoma of Lung
×
1 year
×
Clear all
NCT04741789
2026-03-16
Managed Access Programs for INC280, Capmatinib
Novartis
No longer available